Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51

Jung Ok Lee(Korea University), Hyeon Soo Kim(Korea University)
Breast Cancer Research
October 22, 2019
Cited by 142


Related Papers